5441222025-05-285441222025-05-282025-05-28iso4217:INRxbrli:pureEntero Healthcare Solutions LimitedENTERONewAcquisition (including agreement to acquire)2025-05-272025-05-28Entero Healthcare Solutions LimitedListed Entity (self)Sai RK Pharma Private Limited (SRKPPL)00100000falsefalsefalsefalsePharmaceuticalThe business of SRKPPL is in line of the business of the Company i.e. wholesale distribution of pharmaceutical and other allied products and the acquisition of SRKPPL by the Company shall enable the Company to expand its business in the union territory of Delhi and thereby enabling the Company to generate additional business and revenue on consolidated basis.Nofalse15th August 2025Cash7000000.70.7SRKPPL is engaged in the business of wholesale distribution of pharmaceutical and other allied products. SRKPPL was incorporated on May 10, 2025 and thus the turnover of SRKPPL is NIL. SRKPPL conducts its business only in India.2025-05-10IndiaNote: SRKPPL is considering acquisition of business undertaking of RK Pharma, as a going concern on a slump sale basis which is also in the business of wholesale distribution of pharmaceutical products, surgical and other healthcare and allied products and is a partnership firm owned by Mr. Sanjay Chawala and Mr. Prateek Chawla, who also are the only two shareholders of SRKPPL. The slump sale amount payable shall be discharged by SRKPPL. Details of revenue pertaining to RK Pharma, for last three years are mentioned below: FY 2024-25 (9m annualized) - Rs. 1290 mln FY 2023-24 - Rs. 1061 mln FY 2022-23 - Rs. 775 mln.